Navigation Links
The New Age of Regenerative Medicine: Are Stem Cells the Future of Healing?

MOUNTAIN VIEW, Calif., Nov. 11, 2014 /PRNewswire/ --WHAT:"Regenerative Medicine & Cell Therapy - Multi-Billion Industries with Unlimited Potential" Panel at the 2014 World Stem Cell SummitWHEN:9:30 – 10:30 a.m. CST on Wednesday, Dec. 3, 2014WHERE:Marriott Rivercenter, San Antonio, TexasPANELISTS:Jane C. Andrews, Ph.D., Frost & SullivanGregory A. Bonfiglio, Proteus Venture PartnersChris Mason, MBBS, Ph.D., FRCS, University College London 

Multi-billion dollar companies and small start-ups alike are investing their dollars in the emerging multi-billion dollar regenerative medicine market. There are more clinical trials utilizing stem cells than ever before, especially in the areas of nerve regeneration, cancer treatment, drug therapy and diabetes. The industry is young, expanding rapidly and will take us into a new age of medicine.

This panel will discuss the leading industry trends, highlight current successes and discuss the future of stem cell regenerative medicine. It will also feature presentations on the global capital market and the scientific underpinnings of this cutting-edge and transformative field.

Discussion Points

  • The overall stem cell and regenerative medicine landscape: What it is? How did we get here? What is the size and scope of the capital market and opportunities for investors?
  • The state of the industry and key clinical trials
  • Unique solutions already helping patients
  • Innovative products of the future 
  • Registration

  • Attend this panel by registering for the 2014 World Stem Cell Summit via:
  • Frost & Sullivan clients have access to discounted registration to the RegMed Capital Conference, co-located at the World Stem Cell Summit. Contact Jennifer Carson ( for more information and discounted registration details.
  • Supporting Quotes

  • "When it comes to discovering what stem cells can do, we're currently only at the tip of the iceberg," said Frost & Sullivan Healthcare & Life Sciences Senior Consultant Jane Andrews. "It is astounding what new research is proving and the interest it is generating. So much so in fact, I believe we're entering a new age of medicine where regeneration of cells and tissues will become routine."
  • "With the convergence of innovative technologies, the regenerative medicine industry is entering a phase of explosive growth," said World Stem Cell Summit Founder and Genetics Policy Institute Executive Director Bernard Siegel. "The era of treating formerly incurable medical conditions with stem cell therapies and the use of cells to advance new drug discovery represents the future of medicine. It will impact humanity profoundly. What the Industrial Revolution was to the 19th Century the "Regenerative Medicine Revolution" will be to our 21st Century."
    "The Frost & Sullivan panel at the RegMed Capital Conference is the foundational session of the meeting. It will provide context to all stakeholders for understanding the magnitude of the financial opportunities at the acceleration nexus point of this burgeoning field."
  • Supporting ResourcesFor more information about Frost & Sullivan's global Healthcare practice, please visit:

    About World Stem Cell SummitThe World Stem Cell Summit, produced by the Genetics Policy Institute (GPI), is the largest interdisciplinary, networking meeting of stem cell science and regenerative medicine stakeholders, uniting the diverse community. With the overarching purpose of fostering biomedical research, funding and investments targeting cures, the Summit is the single conference charting the future of this burgeoning field.

    The program provides the research, industry, economic and societal context for understanding how all of the pieces of the stem cell science and regenerative medicine puzzle fit together. Supported by 200 organizing partners, sponsors, exhibitors, endorsing organizations and media partners, the Summit is a three-day showcase of innovation, insight and inspiration.

    About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the Global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies? Contact us: Start the discussion (

    Jennifer Carson
    Frost & Sullivan

    Logo -

    SOURCE Frost & Sullivan
    Copyright©2014 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, A Top Priority Addressed in the 2013 Presidential State of The Union, Announces Plan of "Creating 10,000 Regenerative Humans"
    2. Global Regenerative Medicines Market (Technology, Application and Geography) - Size, Global Trends, Companies, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast to 2020
    3. $1 million Palo Alto Longevity "Fountain of Youth" Prize - Regenerative Processing Plant Accepts the Challenge!
    4. Regenerative Medicine - Global Strategic Business Report 2014
    5. Global Regenerative Medicine (Stem Cell Therapy, Biomaterial and Tissue Engineering) Market (Bone and Joint) - Forecast to 2019
    6. Vivex Biomedical and Akron Biotech: Collaborative Venture in Regenerative Medicine
    7. Biocom CEO Joe Panetta Appointed to California Institute for Regenerative Medicines Independent Citizens Oversight Committee by Governor Jerry Brown
    8. United States Regenerative Medicine Market Analysis to 2016 Featuring Baxter, Medtronic, Stryker & Zimmer
    9. Regenerative Medicine Markets - 2013 Report
    10. Neuralstem CEO To Present At Stem Cells & Regenerative Medicine Congress
    11. BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
    Post Your Comments:
    (Date:6/19/2019)... Pa. (PRWEB) , ... June 19, 2019 , ... ... nuclear receptor and in vitro toxicology testing solutions, announced the addition of the ... kit expands INDIGO’s existing in vitro toxicology offerings and allows researchers to perform ...
    (Date:6/18/2019)... ... June 18, 2019 , ... MY ... W Olympic Blvd Suite 350 Los Angeles, CA, 90064, bringing holistic solutions to ... , MY Education Guru has created individual programs to assist students who have ...
    (Date:6/18/2019)... ... June 18, 2019 , ... Officials with American Physician ... are pleased to announce the acquisition of Leading Edge Medical Associates (LEMA), a ... physicians and 9 advanced practice clinicians care for 115,000 emergency department patients annually ...
    Breaking Medicine Technology:
    (Date:6/14/2019)... ... ... reviewed and approved providers for May 2019. , FL TOP DOCS INCLUDE: , BARIATRIC MEDICINE/SURGERY, ... Dr. Debbie Berlin , CARDIOLOGY, Dr. Nirat Beohar ... Dr. Yamilet Tirado , DERMATOLOGY, Dr. B. Jennifer Berkes ...
    (Date:6/13/2019)... PETERSBURG, Fla. (PRWEB) , ... June 13, 2019 ... ... and research company today announced that it has signed a memorandum of understanding ... (API) for its drug product MMJ-001 and MMJ-002. , MMJ BioPharma Cultivation will ...
    (Date:6/13/2019)... ... 13, 2019 , ... In Partnership with the Smiles for Everyone Foundation ... at its Mesquite, TX office on July 13th. , Dental services provided include same-day ... extractions . For more information, please visit the Monarch Dental website . , ...
    (Date:6/13/2019)... ... June 13, 2019 , ... The ... present the second annual Women|Future Conference and the advisory board that ... better position themselves and their organizations in tomorrow's marketplace. , The mission of ...
    (Date:6/13/2019)... ... ... Clinical Ink , a global clinical trial technology company that is ... chief business officer at Clinical Ink, has been invited to be a panelist in ... July 1, 2019, in Washington, D.C. The workshop, convened under a cooperative agreement with ...
    Breaking Medicine News(10 mins):